645
Participants
Start Date
March 1, 2018
Primary Completion Date
September 1, 2021
Study Completion Date
January 31, 2022
Intensive monitoring
periodic and planned monitoring nurse intervention with phone call
Standard monitoring
standard monitoring of adverse event reaction
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Merck Sharp & Dohme LLC
INDUSTRY
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
OTHER